sever
acut
respiratori
syndrom
sar
coronaviru
cov
produc
devast
primari
viral
pneumonia
diffus
alveolar
damag
mark
increas
circul
cytokin
one
major
cell
type
infect
alveolar
type
ii
cell
howev
innat
immun
respons
primari
human
alveolar
epitheli
cell
infect
sarscov
defin
object
includ
develop
cultur
system
permiss
sarscov
infect
primari
human
type
ii
cell
defin
innat
immun
respons
cultur
primari
human
alveolar
type
ii
cell
airliquid
interfac
al
improv
differenti
greatli
increas
suscept
infect
allow
us
defin
primari
interferon
chemokin
respons
viral
antigen
detect
cytoplasm
infect
type
ii
cell
electron
micrograph
demonstr
secretori
vesicl
fill
virion
viru
rna
concentr
increas
time
infecti
virion
releas
exocytosi
apic
surfac
polar
type
ii
cell
mark
increas
evid
mrna
concentr
interferonb
interferonl
larg
number
proinflammatori
cytokin
chemokin
surpris
find
involv
variabl
express
angiotensinconvert
sarscov
receptor
type
ii
cell
differ
donor
conclus
cultiv
alveolar
type
ii
cell
airliquid
interfac
provid
primari
cultur
studi
pulmonari
innat
immun
respons
infect
sarscov
explor
possibl
therapeut
approach
modul
innat
immun
respons
sever
acut
respiratori
syndromecoronaviru
sarscov
produc
devast
pneumonia
mark
inflammatori
cytokin
respons
mortal
rate
alveolar
epitheli
cell
known
suscept
vivo
extent
infect
submerg
primari
cultur
human
type
ii
cell
limit
defin
cytokin
interferon
respons
infect
report
demonstr
primari
human
alveolar
type
ii
cell
product
infect
sarscov
gener
vigor
innat
immun
respons
critic
featur
infect
human
type
ii
cell
sarscov
involv
maintain
infect
cell
airliquid
interfac
condit
among
unexpect
find
express
angiotensinconvert
receptor
sarscov
quit
variabl
among
differ
individu
cell
differ
donor
differ
suscept
sarscov
infect
alveoli
conduct
airway
viru
replic
vivo
inflammatori
cell
recruit
site
viru
infect
lung
base
situ
hybrid
immunocytochemistri
colleagu
suggest
infect
cell
lung
patient
sar
sourc
proinflammatori
cytokin
primari
goal
research
defin
innat
immun
respons
human
alveolar
type
ii
cell
sarscov
earlier
studi
submerg
human
alveolar
type
ii
cell
insert
detect
low
percentag
infect
cell
could
evalu
innat
immun
respons
howev
cultur
infect
type
ii
cell
airliquid
interfac
al
allow
signific
infect
character
innat
immun
respons
robust
innat
immun
respons
cell
sarscov
infect
consist
mark
elev
mrna
concentr
interferonb
interferonl
result
mirror
find
report
lung
sera
patient
sar
lung
obtain
deidentifi
patient
whose
lung
deem
unsuit
transplant
donat
medic
research
committe
protect
human
subject
nation
jewish
health
deem
use
human
lung
cell
deidentifi
lung
donor
constitut
human
subject
research
therefor
exempt
institut
review
board
approv
correspond
effect
committe
protect
human
subject
nation
jewish
health
avail
upon
request
cell
isol
previous
describ
isol
cell
resuspend
dulbecco
modifi
eagl
medium
supplement
fb
plate
densiti
per
cm
sixwel
millicel
insert
millipor
corp
bedford
precoat
mixtur
matrigel
bd
bioscienc
san
jose
ca
rattail
collagen
cell
adher
hour
medium
switch
day
heatinactiv
human
serum
plu
ngml
keratinocyt
growth
factor
kgf
mm
isobutylmethyl
xanthin
mm
adenosin
monophosph
camp
ngml
ngml
time
cultur
convert
al
condit
cell
incub
addit
day
medium
contain
kia
nm
dexamethason
day
cultur
insert
day
l
condit
cell
use
viru
inocul
harvest
urbani
strain
sarscov
kindli
provid
dr
bellini
center
diseas
control
atlanta
ga
propag
vero
cell
work
infecti
sarscov
perform
biosafeti
level
suit
school
medicin
univers
colorado
aurora
co
type
ii
cell
inocul
apic
surfac
ml
per
sixwel
plate
insert
ml
per
plate
insert
kiad
medium
contain
sarscov
plaqueform
unit
pfu
ml
hour
incub
c
viru
inocula
control
media
aspir
apic
cell
surfac
cultur
incub
total
hour
viru
inocul
al
condit
extract
analyz
viral
cellular
rna
fix
assay
via
electron
microscopi
immunofluoresc
label
antibodi
viral
cell
protein
yield
infecti
viru
titer
wash
apic
cell
surfac
basal
medium
plaqu
assay
vero
cell
method
immunocytochemistri
quantit
infect
cell
viru
product
plaqu
assay
isol
rna
quantit
pcr
flow
cytometri
surfac
biotinyl
statist
analysi
describ
onlin
supplement
initi
studi
sarscov
infect
human
alveolar
type
ii
cell
tradit
submerg
cultur
detect
low
level
infect
subsequ
evalu
varieti
chang
cultur
system
improv
rate
infect
found
suscept
sarscov
infect
mainten
differenti
achiev
cultur
cell
al
millicel
insert
coat
matrix
rattail
collagen
matrigel
provid
medium
contain
well
kgf
isomethylbutyl
xanthin
brcamp
dexamethason
heatinactiv
human
serum
cell
contain
readili
identifi
lamellar
bodi
accord
phase
microscopi
figur
gener
increas
type
ii
cell
differenti
observ
evidenc
express
surfact
protein
sp
figur
shown
figur
airliquid
interfac
condit
increas
express
spa
prospb
prospc
fattyacid
synthas
compar
submerg
condit
experi
howev
magnitud
effect
al
condit
variabl
human
type
ii
cell
experi
primari
rat
type
ii
cell
figur
onlin
supplement
addit
found
increas
express
cultur
ad
find
differ
result
vero
cell
regard
effect
express
figur
gener
level
express
measur
immunoblot
wholecel
extract
slightli
increas
type
ii
cell
cultur
al
condit
concentr
vari
consider
cell
individu
donor
figur
howev
accord
flow
cytometri
surfac
biotinyl
unabl
detect
increas
surfac
express
cell
maintain
al
condit
compar
cell
maintain
submerg
cultur
data
shown
test
whether
type
ii
cell
cultur
al
suscept
sarscov
infect
type
ii
cell
submerg
cultur
human
type
ii
cell
cultur
al
sixwel
insert
inocul
apic
surfac
ml
medium
contain
sarscov
estim
multipl
pfu
cell
allow
adsorb
hour
c
apic
fluid
inoculum
aspir
cell
maintain
al
condit
sarscov
reproduc
caus
product
infect
primari
human
alveolar
type
ii
cell
cultur
al
found
littl
evid
infect
hour
viru
inocul
hour
viru
inocul
infect
cell
contain
viral
antigen
cytoplasm
readili
detect
sarscovinfect
cell
readili
observ
primari
alveolar
type
ii
cultur
millicel
insert
al
although
percentag
infect
cell
vari
consider
differ
area
insert
differ
human
donor
four
donor
percentag
cell
infect
rang
hour
hour
demonstr
sarscovinfect
cell
type
ii
cell
use
antibodi
sever
type
ii
cell
differenti
marker
name
thyroid
transcript
spa
ecadherin
nearli
cell
express
spa
dual
label
show
infect
cell
epitheli
express
spa
figur
marker
chosen
could
readili
detect
methanolfix
cell
requir
identifi
viral
antigen
could
use
rabbit
antibodi
sarscov
nucleocapsid
protein
experi
portion
cell
infect
clear
cell
infect
other
certain
discrep
relat
level
express
coronaviru
rna
synthes
virusinduc
doublemembran
vesicl
cytoplasm
infect
cell
virion
bud
intracellularli
membran
ergolgiintermedi
compart
transport
cytoplasm
secretori
vesicl
releas
cell
exocyt
process
coronavirus
releas
polar
epitheli
cell
exocytosi
apic
plasma
membran
wherea
other
releas
basolater
membran
virion
bud
plasma
membran
although
releas
virion
often
remain
adher
plasma
membran
infect
cell
document
definit
sarscovinfect
cell
alveolar
type
ii
cultur
al
type
ii
cell
inocul
cell
cultur
al
sarscov
fix
embed
plastic
section
perpendicular
insert
observ
electron
microscop
coronaviru
virion
approxim
nm
diamet
observ
within
numer
secretori
vesicl
cell
also
contain
lamellar
bodi
definit
morpholog
featur
type
ii
cell
figur
characterist
doublemembran
vesicl
compris
site
viral
rna
replic
depict
figur
virion
observ
bud
vesicl
figur
adsorb
apic
membran
figur
analyz
sarscov
infect
type
ii
cell
al
use
realtim
quantit
pcr
plaqu
assay
figur
quantit
realtim
pcr
reveal
consist
log
increas
viral
mrna
hour
inocul
shown
six
donor
figur
donor
deidentifi
receiv
number
donor
use
one
type
experi
limit
number
cell
isol
donor
cell
isol
donor
cours
experi
medium
recover
cell
al
wash
apic
surfac
design
time
viru
inocul
titer
releas
viru
apic
wash
well
basolater
medium
plaqu
assay
equal
high
yield
releas
viru
apic
wash
cellassoci
viru
frozen
thaw
sampl
detect
hour
viru
titer
specimen
harvest
hour
lower
similar
littl
viru
detect
basolater
medium
figur
concentr
multipl
proinflammatori
cytokin
chemokin
report
increas
lung
sera
patient
sar
alveolar
type
ii
cell
al
readili
infect
sarscov
abl
measur
chang
express
select
gene
innat
immun
system
cell
respons
sarscov
infect
figur
technic
biosafeti
reason
attempt
measur
concentr
interferon
cytokin
protein
infect
cultur
sarscov
infect
type
ii
cell
induc
markedli
increas
concentr
mrna
encod
type
type
iii
interferon
well
interferonrespons
gene
figur
sarscov
infect
type
ii
cultur
also
elicit
larg
increas
concentr
chemokin
recruit
inflammatori
cell
thu
human
alveolar
type
ii
cell
capabl
initi
robust
innat
immun
respons
could
contribut
cytokin
chemokin
measur
lung
sera
patient
sar
addit
chemoattract
releas
epitheli
cell
would
expect
recruit
inflammatori
cell
vivo
initi
innat
immun
respons
focu
studi
involv
differenti
human
type
ii
cell
also
perform
limit
number
experi
determin
whether
type
ilik
cell
transdifferenti
type
ii
cell
grown
al
condit
also
suscept
sarscov
previou
studi
detect
sarscov
infect
human
alveolar
type
ilik
cell
submerg
condit
protein
express
level
detect
pilot
experi
unselect
donor
detect
littl
infect
type
ilik
cell
al
condit
hour
inocul
howev
undertook
screen
select
donor
ie
patient
express
high
concentr
freshli
isol
cell
observ
transdifferenti
type
ilik
cell
could
infect
sarscov
figur
henc
alveolar
type
ilik
cell
al
also
suscept
sarscov
although
much
less
suscept
infect
differenti
human
type
ii
cell
goal
studi
involv
develop
primari
cultur
system
human
alveolar
type
ii
cell
permiss
sarscov
infect
innat
immun
respons
infect
could
defin
human
alveolar
type
ii
cell
maintain
al
well
differenti
figur
permiss
sarscov
infect
shown
immunocytochemistri
increas
synthesi
viral
rna
protein
product
releas
infecti
virion
although
airliquid
interfac
cultur
condit
greatli
increas
suscept
type
ii
cell
sarscov
mechan
increas
suscept
infect
yet
establish
lung
littl
fluid
present
apic
surfac
alveolar
epithelium
henc
al
condit
approxim
condit
vivo
al
cultur
condit
improv
differenti
state
type
ii
alveolar
epitheli
cell
vitro
greatli
enhanc
suscept
sarscov
infect
innat
immun
serv
first
respons
protect
host
cell
viral
infect
characterist
innat
immun
respons
pathogen
significantli
shape
subsequ
adapt
immun
respons
affect
outcom
infect
alveolar
epithelium
becom
infect
infect
cell
alert
cell
organ
infect
secret
cytokin
chemokin
infect
epitheli
cell
like
first
respond
initi
innat
immun
respons
earliest
respons
human
alveolar
type
ii
cell
influenza
viru
infect
involv
express
interferon
interferonrespons
gene
presum
interferon
respons
increas
resist
neighbor
cell
infect
next
phase
innat
immun
respons
involv
express
cytokin
attract
activ
immun
cell
stimul
neighbor
cell
amplifi
defens
respons
greatli
secret
addit
cytokin
chemokin
innat
respons
also
signal
bone
marrow
releas
addit
inflammatori
cell
initi
adapt
immun
respons
recruit
antigenspecif
lymphocyt
studi
measur
mrna
encod
interferonb
interferonl
markedli
elev
respons
sarscov
infect
interferon
report
elev
experiment
sarscov
infect
primat
cell
line
infect
sar
cov
import
innat
immun
respons
may
help
control
sarscov
infect
cytokin
respons
human
type
ii
alveolar
epitheli
cell
al
similar
detect
sera
lung
patient
nonhuman
primat
infect
sarscov
colleagu
suggest
resid
lung
epitheli
cell
subsequ
recruit
inflammatori
cell
constitut
primari
sourc
elev
cytokin
patient
infect
sarscov
epithelialderiv
cytokin
play
import
role
acut
lung
injuri
pathogenesi
sar
data
show
type
ii
alveolar
cell
like
contribut
high
concentr
cytokin
chemokin
detect
gasexchang
portion
lung
patient
sar
sera
patient
sar
cytokin
increas
rapidli
similarli
type
ii
cell
al
level
mrna
express
increas
fold
hour
viru
inocul
figur
cytokin
appear
predict
clinic
cours
outcom
sar
concentr
mrna
encod
elev
approxim
sarscovinfect
alveolar
type
ii
cultur
al
figur
particular
experi
evalu
ultraviolet
lightinactiv
viru
knew
previou
studi
type
ii
cell
present
cytokin
interferon
respons
ultraviolet
lightinactiv
influenza
addit
studi
requir
defin
cellcel
interact
wherebi
infect
epitheli
cell
signal
nearbi
uninfect
parenchym
cell
inflammatori
cell
found
rat
alveolar
type
ilik
cell
infect
rat
coronaviru
stimul
noninfect
cell
cultur
secret
cytokin
chemokin
mechan
paracrin
signal
releas
infect
type
ii
cell
activ
inflammasom
may
also
play
import
role
protect
type
ii
cell
infect
amplifi
innat
immun
respons
explor
hypothesi
increas
rate
sarscov
infect
type
ii
cell
al
condit
attribut
increas
concentr
sarscov
receptor
observ
type
ii
cell
donor
express
higher
concentr
cultur
condit
increas
express
gener
correl
higher
suscept
sarscov
infect
howev
measur
concentr
cell
enough
differ
donor
also
inocul
sarscov
measur
extent
viru
infect
prove
quantit
although
immunoblot
show
modest
variabl
increas
express
type
ii
cell
cultur
al
compar
submerg
conditon
detect
consist
increas
surfac
express
either
flow
cytometri
surfac
biotinyl
data
shown
similarli
transdifferenti
type
ii
cell
al
type
ilik
cell
express
low
level
observ
littl
sarscov
infect
howev
type
ilik
cell
transdifferenti
type
ii
cell
donor
select
express
high
concentr
observ
infect
type
ilik
cell
figur
demonstr
clear
increas
surfac
express
al
condit
conclud
enhanc
role
infect
type
ii
cell
al
attribut
sole
concentr
focu
potenti
ad
cultur
de
lang
colleagu
report
decreas
express
vero
cell
howev
shown
figur
found
actual
increas
express
primari
human
alveolar
type
ii
cell
henc
ad
increas
express
therebi
increas
sarscov
infect
previous
report
effect
human
type
ii
cell
note
decreas
spc
spd
exert
littl
effect
spa
spb
slight
decreas
spd
could
enhanc
sar
infect
although
unlik
base
experi
anoth
coronaviru
spd
make
major
differ
infect
human
alveolar
macrophag
nevertheless
spd
report
interact
sar
spike
glycoprotein
attach
protein
altern
al
cultur
condit
may
increas
level
express
coreceptor
sarscov
pilot
experi
find
consist
increas
accord
flow
cytometri
al
condit
data
shown
anoth
consider
involv
detail
inocul
volum
apic
fluid
al
cultur
inoculum
aspir
cell
wash
inoculum
persist
surfac
fluid
durat
experi
perhap
al
condit
facilit
multipl
cycl
viru
infect
exampl
first
cycl
viru
replic
newli
synthes
viru
would
releas
scant
amount
fluid
apic
surfac
concentr
viru
might
acceler
secondari
round
infect
pilot
studi
observ
increas
suscept
type
ii
cell
sarscov
infect
requir
al
cultur
condit
viru
inocul
investig
identifi
lung
cell
could
infect
sarscov
neonat
mice
cell
express
club
cell
secretori
protein
alveolar
epitheli
cell
marker
human
lung
tissu
cell
express
cytokeratin
surfact
protein
cell
differ
express
club
cell
secretori
protein
express
surfact
protein
cytokeratin
contain
characterist
lamellar
bodi
conclus
cultur
al
render
primari
human
alveolar
type
ii
cell
suscept
product
sarscov
infect
cell
mount
robust
innat
immun
respons
similar
observ
lung
sera
patient
sar
type
ii
alveolar
epitheli
cell
cultur
al
offer
excel
vitro
system
isol
propag
emerg
respiratori
virus
present
fastidi
requir
growth
highli
differenti
human
lung
cell
cultur
also
provid
excel
vitro
model
evalu
effect
candid
therapeut
target
innat
immun
respons
respiratori
viru
infect
author
disclosur
avail
text
articl
wwwatsjournalsorg
figur
innat
immun
respons
alveolar
type
ii
cell
sarscov
infect
type
ii
cell
al
cultur
inocul
sarscov
describ
materi
method
inocul
period
inoculum
aspir
cultur
harvest
hour
later
specif
mrna
concentr
chemokin
cytokin
measur
quantit
rtpcr
normal
constitut
probe
acid
ribosom
phosphoprotein
white
bar
repres
data
mockinocul
insert
black
bar
repres
data
sarscovinfect
insert
hour
viru
inocul
signific
increas
detect
mrna
concentr
involv
interferonrespons
gene
b
hour
viru
inocul
mark
increas
express
select
gene
evid
p
p
p
result
deriv
six
independ
donor
duplic
insert
condit
time
